Data Insights

By Company Name

By Disease Name

By Drug Name

By Themes

Showing 4 results out of 4

Company profileOctapharma

Access the most comprehensive report about Octapharma available on the market

Buy Now

Data Insights

C1 esterase inhibitor (human) is under clinical development by Octapharma and currently in Phase III for Hereditary Angioedema (HAE) (C1...

Data Insights

Immune globulin (human) is under clinical development by Octapharma and currently in Phase II for Neuropathy. According to GlobalData, Phase...

Data Insights

Immune globulin (human) is under clinical development by Octapharma and currently in Phase III for Unspecified Neurologic Disorders. According to...

Data Insights

Immune globulin (human) is under clinical development by Octapharma and currently in Phase II for Neuropathy. According to GlobalData, Phase...